Cargando…
Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates
The selective, high affinity A(2B) adenosine receptor (AdoR) antagonists that were synthesized by several research groups should aid in determining the role of the A(2B) AdoR in inflammatory diseases like asthma or rheumatoid arthritis (RA) and angiogenic diseases like diabetic retinopathy or cancer...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721775/ https://www.ncbi.nlm.nih.gov/pubmed/18568423 http://dx.doi.org/10.1007/s11302-008-9119-x |